Stay updated on Trametinib and Docetaxel for KRAS+ NSCLC Clinical Trial
Sign up to get notified when there's something new on the Trametinib and Docetaxel for KRAS+ NSCLC Clinical Trial page.

Latest updates to the Trametinib and Docetaxel for KRAS+ NSCLC Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoChange DetectedRevision: v3.3.3 is added to the page, and HHS Vulnerability Disclosure and Revision: v3.3.2 are removed.SummaryDifference0.0%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedNew entries for Contacts/Locations and Study Status were added on 2025-11-14 and 2025-12-02, and an entry was removed on 2025-11-10.SummaryDifference0.1%

- Check41 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2 on the page header. This reflects a backend/version update with no visible changes to the study record content or user experience.SummaryDifference0.0%

- Check48 days agoChange DetectedThe site-wide government funding status notice banner has been removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check55 days agoChange DetectedOn 2025-11-10, the history adds Contacts/Locations and Study Status (entry 437). A deletion was recorded on 2025-09-22.SummaryDifference0.1%

- Check69 days agoChange DetectedNew entries appear in the Record History, reflecting updated version dates and status changes for the study (including status and contacts/locations updates). These are administrative changes and do not alter the study data.SummaryDifference0.0%

Stay in the know with updates to Trametinib and Docetaxel for KRAS+ NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Trametinib and Docetaxel for KRAS+ NSCLC Clinical Trial page.